Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Don’t Be Fooled by Barnes & Noble, Inc. (BKS)’s Pop

U.S. stocks are ahead this morning, with the S&P 500 and the narrower, price-weighted Dow Jones Industrial Average up 0.35% and 0.36%, respectively, at 10:05 a.m. EDT.

Barnes & Noble, Inc. (NYSE:BKS) moves on, but will it move up?

Barnes & Noble, Inc. (NYSE:BKS)

Less than two weeks after bookseller Barnes & Noble, Inc. (NYSE:BKS) released abysmal quarterly results, CEO William Lynch is out, having resigned after three years on the job. The departure is a final acknowledgement of Barnes & Noble’s failed digital strategy; Mr. Lynch championed the development of the Nook e-book store, e-reader, and tablets. Last month, the company announced it would no longer manufacture its own Nook tablets.

Barnes & Noble, Inc. (NYSE:BKS)’s future course is highly uncertain, but Lynch’s exit and the promotion of Michael Huseby to CEO of Nook media, which covers the company’s digital business and its college book stores, suggests a breakup may be in the works (Mitchell Klipper remains chief executive of the traditional bookstore activity). In January, executive chairman Leonard Riggio, who owns 30% of the company, produced an offer to buy the traditional book stores.

Two weeks ago, commenting on B&N’s results, I concluded:

As far as its bricks-and-mortar stores are concerned, Barnes & Noble, Inc. (NYSE:BKS) is a business in decline, perhaps even terminal decline. There may be a size at which the company can produce steady profits, but it’s hard to say quite where that “sweet spot” lies (assuming it even exists.) For investors, it’s not impossible to make money speculating on businesses in that situation, but it requires timing, luck, and constant vigilance. There are certainly easier ways for investors to eke out a return.

As of yesterday’s close, the shares are up more than 13% since then. It appears June 25 marked a short-term bottom in the stock:

BKS Chart

BKS data by YCharts.

And the shares are up an extra 2.8% this morning. Nevertheless, I’m going to stick with my initial assessment at this stage. With an enterprise value of 8.1 times the (highly uncertain) estimate of the next 12 months’ EBITDA (earnings before interest, taxes, depreciation, and amortization — a measure of cashflow), I don’t think the company is cheap enough to account for the decline in its businesses. Furthermore, one need only go back as far as February on this year’s chart to verify that there is plenty of potential downside to the stock price. In sum, Barnes & Noble, Inc. (NYSE:BKS) is not a bottom-fishing candidate.

The article Don’t Be Fooled by Barnes & Noble’s Pop originally appeared on and is written by Alex Dumortier, CFA.

Fool contributor Alex Dumortier, CFA has no position in any stocks mentioned; you can follow him on LinkedIn. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.